INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

RTTNews | 915 दिनों पहले
INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

(RTTNews) - Biotechnology company INOVIO Pharmaceuticals, Inc. (INO) announced Thursday positive results from a Phase 1b clinical trial evaluating INO-4201, a DNA vaccine candidate, as a booster in healthy adult participants who previously received a single injection of Ervebo.

In the trial, INO-4201 was well-tolerated and boosted humoral responses in 100% (36 of 36) of treated participants.

INO-4201 was evaluated in a 46-participant randomized, placebo-controlled Phase 1b trial (NCT04906629) to assess its safety, tolerability, and immunogenicity in healthy adult participants who previously received a single injection of Ervebo, a vaccine approved by the U.S. Food and Drug Administration for the prevention of disease caused by Zaire ebolavirus in individuals 18 years of age and older.

The participants were dosed with 1 mg of INO-4201 injected intradermally followed by electroporation using our investigational proprietary smart device, CELLECTRA. The trial was designed to test whether INO-4201 can be used as a booster in healthy participants previously vaccinated with Ervebo.

For More Such Health News, visit rttnews.com

टैग: INO
read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | 665 दिनों पहले
Australian Market Maintains Early Gains In Mid-market

Australian Market Maintains Early Gains In Mid-market

The Australian stock market is maintaining its early gains in mid-market moves on Wednesday, extending to the gains in the previous two sessions, with the benchmark S&P/ASX 200 moving above the 8,800 level to all-time record highs, despite the broadly negative cues from Wall Street overnight, with gains across most sectors led by mining and financial stocks.
RTTNews | 31 मिनटों पहले
Asian Markets Track Wall Street Lower

Asian Markets Track Wall Street Lower

Asian stock markets are trading mostly lower on Wednesday, following the broadly negative cues from Wall Street overnight, amid the ongoing trade concerns following US President Donald Trump's latest comments on tariffs. Trump said he will be announcing new tariffs on semiconductors and chips as well as up to 250 percent on pharmaceuticals imported into the U.S.
RTTNews | 55 मिनटों पहले
Sensex, Nifty Likely To Open On Flat Note On Tariff Worries

Sensex, Nifty Likely To Open On Flat Note On Tariff Worries

Indian shares look set to open on a flat note Wednesday as investors react to U.S. President Donald Trump's latest tariff threats and await the Reserve Bank of India's policy announcement, with investors expecting a rate pause and dovish signals to offset rising external risks.
RTTNews | 1घंटे 27 मिनट पहले
Lower Open Called For Thai Stock Market

Lower Open Called For Thai Stock Market

The Thai stock market has moved higher in back-to-back sessions, gathering almost 30 points or 2.5 percent along the way. The Stock Exchange of Thailand now sits just above the 1,245-point plateau and it's expected to open under pressure on Wednesday.
RTTNews | 2घंटे 0 मिनट पहले